Anna Gudmundsdottir

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ACTA PAEDIATRICA. 2024;113(3):461-470

Treating very preterm European infants with inhaled nitric oxide increased in-hospital mortality but did not affect neurodevelopment at 5 years of age

Siljehav V; Gudmundsdottir A; Tjerkaski J; Aubert AM; Cuttini M; Koopman C; Maier RF; Zeitlin J; Aden U
Article: JAMA NETWORK OPEN. 2023;6(9):e2332413

Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm

Ehrhardt H; Aubert AM; Aden U; Draper ES; Gudmundsdottir A; Varendi H; Weber T; Zemlin M; Maier RF; Zeitlin J
Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(3):667

Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants

Gudmundsdottir A; Bartocci M; Picard O; Ekstrom J; Chakhunashvili A; Bohlin K; Attner C; Printz G; Karlsson M; Mohlkert L-A; Karlen J; Pegelow Halvorsen C; Edstedt Bonamy A-K
Article: JAMA PEDIATRICS. 2021;175(9):911-918

Comparison of Respiratory Support After Delivery in Infants Born Before 28 Weeks' Gestational Age The CORSAD Randomized Clinical Trial

Donaldsson S; Drevhammar T; Li Y; Bartocci M; Rettedal SI; Lundberg F; Odelberg-Johnson P; Szczapa T; Thordarson T; Pilypiene I; Thorkelsson T; Soderstrom L; Chijenas V; Jonsson B
Article: ACTA PAEDIATRICA. 2021;110(2):510-520

The type and timing of patent ductus arteriosus treatment was associated with neurodevelopment when extremely preterm infants reached 6.5 years

Gudmundsdottir A; Brostrom L; Skiold B; Kallen K; Serenius F; Norman M; Aden U; Bonamy A-KE
Article: NEONATOLOGY. 2017;111(4):367-375

Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes

Bonamy A-KE; Gudmundsdottir A; Maier RF; Toome L; Zeitlin J; Bonet M; Fenton A; Hasselager AB; van Heijst A; Gortner L; Milligan D; Van Reempts P; Boyle EM; Norman M
Article: NEONATOLOGY. 2015;107(2):87-92

Timing of Pharmacological Treatment for Patent Ductus Arteriosus and Risk of Secondary Surgery, Death or Bronchopulmonary Dysplasia: A Population-Based Cohort Study of Extremely Preterm Infants

Gudmundsdottir A; Johansson S; Hakansson S; Norman M; Kallen K; Bonamy A-K

Alla övriga publikationer

Thesis / dissertation: 2019

Patent ductus arteriosus in extremely preterm infants : characteristics, risk factors and treatment decisions

Guðmundsdóttir, Anna
Letter: NEONATOLOGY. 2015;107(4):257

The Importance of Echocardiography and an Individual Approach to Patent Ductus Arteriosus Treatment in Extremely Preterm Infants

Gudmundsdottir A; Johansson S; Hakansson S; Norman M; Kallen K; Bonamy A-K

Anställningar

Anknuten till Forskning, Kvinnors och barns hälsa, Karolinska Institutet, 2024-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2019

Handledare

Line Trondsen Hetteberg, Defining the patent ductus arteriosus shunt significance and association with the development of retinopathy of prematurity in extremely preterm infants - PDA diagnostics control in the Mega Donna Mega cohort, 2023

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI